Apr 17, 2026 Posted on 17 April 202617 April 2026 Lilly debuts more Foundayo data as FDA requests post-marketing trials
Mar 12, 2026 Posted on 12 March 202612 March 2026 FDA issues warning to Novo Nordisk on unreported semaglutide safety events
Feb 03, 2026 Posted on 3 February 202612 March 2026 Novo Nordisk starts €432m Ireland facility upgrade for oral Wegovy production
Jan 15, 2026 Posted on 15 January 202615 January 2026 GE HealthCare’s CEO maintains disciplined M&A strategy
